L-Threonine derivative-1

CAS No. 852055-88-0

L-Threonine derivative-1( —— )

Catalog No. M33222 CAS No. 852055-88-0

L-Threonine derivative-1 is acetylsalicylic acid-L-threonine ester with potential analgesic activity.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 246 In Stock
5MG 411 In Stock
10MG 562 In Stock
25MG 866 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    L-Threonine derivative-1
  • Note
    Research use only, not for human use.
  • Brief Description
    L-Threonine derivative-1 is acetylsalicylic acid-L-threonine ester with potential analgesic activity.
  • Description
    L-Threonine derivative-1 is a acetylsalicylic-L-threonine ester extracted from patent US 20060287244 A1.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    852055-88-0
  • Formula Weight
    281.26
  • Molecular Formula
    C13H15NO6
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O(C(C)=O)C1=C(C(O[C@@H]([C@@H](C(O)=O)N)C)=O)C=CC=C1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. V. Chandran. L-Threonine derivatives of high therapeutic index. US 20060287244 A1.
molnova catalog
related products
  • Kisspeptin 234

    kisspeptin receptor (KISS1, GPR54) antagonist; kisspeptin-10 analog. Inhibits kisspeptin-10 stimulation of inositol phosphate (IP) (IC50 = 7 nM) and release of gonadotrophin-releasing hormone (GnRH).

  • Fructosylvaline

    Fructosylvaline(Fru-val) is present in miso, white wine and sake and has been associated with oxidative browning of white wine and sake.

  • Valbenazine

    A novel, highly selective vesicular monoamine transporter 2 (VMAT2) inhibitor; is approved for the treatment of tardive dyskinesia.